Skip to main content
. 2014 Jul 20;20:1255–1262. doi: 10.12659/MSM.890598

Table 1.

Relation between demographic and tumor characteristics of patients based on Claudin 1 expression.

Claudin 1 mild loss N (%) Claudin 1 modarate to marked loss N (%) P value
Sex 0.334
 Female 9 (52.9) 21 (39.6)
 Male 8 (47.1) 32 (60.4)

Age 62.5±13.5 61.9±14 0.8

T stage 0.004
 T2 1 (5.9) 1 (1.9)
 T3 16 (94.1) 33 (62.3)
 T4 0 19 (27.1)

N status
 Node negative 15 (88.2) 13 (25.4) <0.001
 Node positive 2 (11.8) 40 (75.5)

M status 0.214
 Metastasis negative 15 (88.2) 39 (73.6)
 Metastasis positive 2 (11.8) 14 (26.4)

Stage
 Stage 1 1 (5.9) 0
 Stage 2 14 (82.4) 11 (20.8) <0.001
 Stage 3 0 29 (54.7)
 Stage 4 2 (11.8) 13 (24.5)

Histological sub-type 0.552
 Conventional adenocarcinoma 15 (88.2) 42 (79.2)
 Mucinous adenocarcinoma 2 (11.8) 8 (15.1)
 Signet ring cell adenocarcinoma 0 3 (5.7)

Grade 0.026
 Grade 1 15 (88.2) 31 (58.5)
 Grade 2 2 (11.8) 22 (41.5)

Perineural invasion 0.04
 Negative 7 (41.1) 9 (17)
 Positive 10 (58.8) 44 (83)

Lymphovascular invasion 0.024
 Negative 7 (41.1) 8 (15.1)
 Positive 10 (58.8) 45 (84.9)

Lymphocytic response 0.009
 Negative 7 (41.1) 40 (%75.5)
 Positive 10 (58.8) 13 (24.5)